Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,701 | 328 | 99.2% |
| Education | $59.16 | 7 | 0.6% |
| Travel and Lodging | $15.23 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $2,785 | 142 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,704 | 27 | $0 (2024) |
| Lilly USA, LLC | $641.94 | 19 | $0 (2024) |
| Abbott Laboratories | $587.47 | 29 | $0 (2024) |
| Novo Nordisk Inc | $571.52 | 19 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $465.18 | 8 | $0 (2024) |
| PFIZER INC. | $384.92 | 21 | $0 (2020) |
| Amarin Pharma Inc. | $344.95 | 12 | $0 (2021) |
| ABBVIE INC. | $316.08 | 14 | $0 (2024) |
| GlaxoSmithKline, LLC. | $271.31 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,408 | 43 | AstraZeneca Pharmaceuticals LP ($374.88) |
| 2023 | $1,545 | 49 | Amgen Inc. ($436.74) |
| 2022 | $1,043 | 37 | AstraZeneca Pharmaceuticals LP ($249.96) |
| 2021 | $1,428 | 58 | Amgen Inc. ($501.64) |
| 2020 | $787.26 | 35 | Amgen Inc. ($490.94) |
| 2019 | $1,037 | 34 | AstraZeneca Pharmaceuticals LP ($383.86) |
| 2018 | $1,318 | 45 | Amgen Inc. ($369.67) |
| 2017 | $1,209 | 35 | Boehringer Ingelheim Pharmaceuticals, Inc. ($204.85) |
All Payment Transactions
336 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: Diabetes Care | ||||||
| 12/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: Inflammation | ||||||
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Inflammation | ||||||
| 12/03/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Oncology | ||||||
| 11/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $31.20 | General |
| Category: Endocrinology | ||||||
| 10/14/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: Diabetes Care | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/02/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: Inflammation | ||||||
| 09/24/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: Diabetes Care | ||||||
| 09/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $7.36 | General |
| Category: Inflammation | ||||||
| 08/14/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $143.90 | General |
| Category: Bone Health | ||||||
| 08/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $10.89 | General |
| Category: Inflammation | ||||||
| 08/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Inflammation | ||||||
| 08/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: Diabetes Care | ||||||
| 07/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Inflammation | ||||||
| 06/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: Diabetes Care | ||||||
| 06/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Diabetes | ||||||
| 06/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $31.95 | General |
| Category: DIABETES | ||||||
| 06/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $5.06 | General |
| Category: Inflammation | ||||||
| 05/31/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $7.74 | General |
| Category: Inflammation | ||||||
| 05/30/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: Diabetes Care | ||||||
| 05/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $29.37 | General |
| Category: Diabetes | ||||||
| 05/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 289 | 415 | $62,690 | $39,017 |
| 2022 | 9 | 348 | 483 | $69,200 | $44,336 |
| 2021 | 9 | 369 | 491 | $62,385 | $43,376 |
| 2020 | 9 | 456 | 641 | $78,950 | $44,960 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 132 | 250 | $40,000 | $26,443 | 66.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 46 | 46 | $13,800 | $6,457 | 46.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 34 | 35 | $2,690 | $2,593 | 96.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 30 | $3,750 | $2,052 | 54.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 37 | 38 | $1,330 | $1,270 | 95.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 14 | 16 | $1,120 | $202.56 | 18.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 131 | 257 | $41,120 | $27,525 | 66.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 36 | 36 | $10,800 | $5,148 | 47.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 42 | 49 | $6,125 | $3,576 | 58.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 23 | 25 | $3,750 | $2,676 | 71.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 39 | 39 | $2,535 | $2,486 | 98.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 41 | 41 | $1,435 | $1,357 | 94.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 12 | 12 | $1,560 | $823.84 | 52.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 13 | $1,105 | $604.62 | 54.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 11 | 11 | $770.00 | $139.05 | 18.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 131 | 241 | $37,490 | $25,253 | 67.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 37 | 37 | $6,475 | $5,425 | 83.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 28 | 32 | $4,780 | $3,509 | 73.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 38 | 45 | $5,540 | $3,427 | 61.9% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 37 | 37 | $2,405 | $2,405 | 100.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 52 | 52 | $1,820 | $997.88 | 54.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 12 | 13 | $1,690 | $976.30 | 57.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 19 | 19 | $1,615 | $957.60 | 59.3% |
| 90756 | Vaccine for influenza derived from cell cultures for injection into muscle, quadrivalent, antibiotic free, 0.5ml dosage | Office | 2021 | 15 | 15 | $570.00 | $425.55 | 74.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 153 | 316 | $47,400 | $25,966 | 54.8% |
About Dr. Khin Oo, MD
Dr. Khin Oo, MD is a Internal Medicine healthcare provider based in Pasadena, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588638043.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Khin Oo, MD has received a total of $9,775 in payments from pharmaceutical and medical device companies, with $1,408 received in 2024. These payments were reported across 336 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($9,701).
As a Medicare-enrolled provider, Oo has provided services to 1,462 Medicare beneficiaries, totaling 2,030 services with total Medicare billing of $171,689. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Pasadena, CA
- Active Since 02/13/2006
- Last Updated 02/08/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1588638043
Products in Payments
- Otezla (Drug) $1,101
- FARXIGA (Drug) $1,034
- EVENITY (Biological) $653.30
- Aimovig (Biological) $500.38
- JARDIANCE (Drug) $458.62
- MOUNJARO (Drug) $354.39
- Vascepa (Drug) $344.95
- FREESTYLE LIBRE 2 (Device) $344.15
- Repatha (Biological) $329.43
- Ozempic (Drug) $328.51
- UBRELVY (Drug) $294.55
- BREZTRI (Drug) $249.96
- ENTRESTO (Drug) $219.22
- FREESTYLE LIBRE 3 (Device) $218.48
- Prolia (Biological) $201.20
- TRULICITY (Drug) $181.46
- RYBELSUS (Drug) $160.26
- Kerendia (Drug) $153.17
- XARELTO (Drug) $148.54
- LYRICA (Drug) $147.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pasadena
Dr. Yuan Yuan, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $523,801
Christopher Dagher, M.d, M.D
Internal Medicine — Payments: $103,615
Peter Haddad, M.d, M.D
Internal Medicine — Payments: $87,600
Dr. Andrew Williams, M.d, M.D
Internal Medicine — Payments: $85,273
Joseph Dellinger, Md, MD
Internal Medicine — Payments: $77,175
Dr. Helen Moon, M.d, M.D
Internal Medicine — Payments: $61,882